Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Feb;83(2):662–668. doi: 10.1172/JCI113930

Intracellular and nuclear binding of [3H]dihydrotestosterone in cultured genital skin fibroblasts of patients with severe hypospadias.

H U Schweikert 1, M Schlüter 1, G Romalo 1
PMCID: PMC303727  PMID: 2913055

Abstract

Androgens stimulate the development and growth of the male external genitalia. Because hypospadias is the most common congenital defect of the male urethra and because in most cases the cause of this malformation is unknown, we examined the hypothesis that the etiology of the severe forms of this disorder, which is frequently associated with other genital anomalies, might be explained by receptor abnormalities. Intracellular and nuclear binding of androgens were determined in cultured genital skin fibroblasts from 10 males who underwent circumcision for phimosis (controls A), 2 patients with 5 alpha-reductase deficiency (controls B), and 11 patients with severe forms of hypospadias of unknown etiology. Genital skin fibroblast monolayers were incubated for 60 min at 37 degrees C with varying concentrations of [3H]-dihydrotestosterone ([3H]DHT), and specific binding in whole cells and nuclei was measured. Maximum binding (Bmax) in the whole cell assay averaged 0.88 +/- 0.15 fmol . microgram DNA-1 (mean +/- SD) in the control group (controls A, 0.89 +/- 0.16 fmol . microgram DNA-1; controls B, 0.85 fmol . microgram DNA-1) and 0.7 +/- 0.25 fmol . microgram DNA-1 in the patients with hypospadias. In the latter group, Bmax in six patients was below the minimum values determined in the controls. Maximum specific nuclear binding in the control groups averaged 43% (range, 30-55%) of the corresponding intracellular binding. In contrast, nuclear binding in strains from patients with hypospadias was lower (range, 0-12% of whole cell Bmax). In particular, no high affinity saturable nuclear [3H]DHT binding could be measured in 6 of the 11 patients. We interpret these data to suggest that defective intracellular and/or nuclear binding might be the cause of defective genital development in some patients with severe hypospadias.

Full text

PDF
662

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarskog D. Maternal progestins as a possible cause of hypospadias. N Engl J Med. 1979 Jan 11;300(2):75–78. doi: 10.1056/NEJM197901113000206. [DOI] [PubMed] [Google Scholar]
  2. Brown T. R., Migeon C. J. Cultured human skin fibroblasts: a model for the study of androgen action. Mol Cell Biochem. 1981 Apr 13;36(1):3–22. doi: 10.1007/BF02354827. [DOI] [PubMed] [Google Scholar]
  3. Brown T. R., Rothwell S. W., Migeon C. J. Comparison of methyltrienolone and dihydrotestosterone binding and metabolism in human genital skin fibroblasts. J Steroid Biochem. 1981 Oct;14(10):1013–1022. doi: 10.1016/0022-4731(81)90209-0. [DOI] [PubMed] [Google Scholar]
  4. Collier M. E., Griffin J. E., Wilson J. D. Intranuclear binding of [3H]dihydrotestosterone by cultured human fibroblasts. Endocrinology. 1978 Oct;103(4):1499–1505. doi: 10.1210/endo-103-4-1499. [DOI] [PubMed] [Google Scholar]
  5. Eil C., Crawford J. D., Donahoe P. K., Johnsonbaugh R. E., Loriaux D. L. Fibroblast androgen receptors in patients with genitourinary anomalies. J Androl. 1984 Sep-Oct;5(5):313–320. doi: 10.1002/j.1939-4640.1984.tb00795.x. [DOI] [PubMed] [Google Scholar]
  6. Griffin J. E., Wilson J. D. The syndromes of androgen resistance. N Engl J Med. 1980 Jan 24;302(4):198–209. doi: 10.1056/NEJM198001243020404. [DOI] [PubMed] [Google Scholar]
  7. Gyorki S., Warne G. L., Khalid B. A., Funder J. W. Defective nuclear accumulation of androgen receptors in disorders of sexual differentiation. J Clin Invest. 1983 Sep;72(3):819–825. doi: 10.1172/JCI111052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hay S., Barbano H. Independent effects of maternal age and birth order on the incidence of selected congenital malformations. Teratology. 1972 Dec;6(3):271–279. doi: 10.1002/tera.1420060304. [DOI] [PubMed] [Google Scholar]
  9. Johnson L., George F. W., Neaves W. B., Rosenthal I. M., Christensen R. A., Decristoforo A., Schweikert H. U., Sauer M. V., Leshin M., Griffin J. E. Characterization of the testicular abnormality in 5 alpha-reductase deficiency. J Clin Endocrinol Metab. 1986 Nov;63(5):1091–1099. doi: 10.1210/jcem-63-5-1091. [DOI] [PubMed] [Google Scholar]
  10. Jukier L., Kaufman M., Pinsky L., Peterson R. E. Partial androgen resistance associated with secondary 5 alpha-reductase deficiency: identification of a novel qualitative androgen receptor defect and clinical implications. J Clin Endocrinol Metab. 1984 Oct;59(4):679–688. doi: 10.1210/jcem-59-4-679. [DOI] [PubMed] [Google Scholar]
  11. Keenan B. S., McNeel R. L., Gonzales E. T. Abnormality of intracellular 5 alpha-dihydrotestosterone binding in simple hypospadias: studies on equilibrium steroid binding in sonicates of genital skin fibroblasts. Pediatr Res. 1984 Feb;18(2):216–220. doi: 10.1203/00006450-198402000-00020. [DOI] [PubMed] [Google Scholar]
  12. Knorr D., Beckmann D., Bidlingmaier F., Helmig F. J., Sippell W. G. Plasma testosterone in male puberty. II. hCG stimulation test in boys with hypospadia. Acta Endocrinol (Copenh) 1979 Feb;90(2):365–371. [PubMed] [Google Scholar]
  13. Kovacs W. J., Griffin J. E., Weaver D. D., Carlson B. R., Wilson J. D. A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state. J Clin Invest. 1984 Apr;73(4):1095–1104. doi: 10.1172/JCI111295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Leshin M., Griffin J. E., Wilson J. D. Hereditary male pseudohermaphroditism associated with an unstable form of 5 alpha-reductase. J Clin Invest. 1978 Sep;62(3):685–691. doi: 10.1172/JCI109176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SHAPIRO R. N., EDDY W., FITZGIBBON J., O'BRIEN G. The incidence of congenital anomalies discovered in the neonatal period. Am J Surg. 1958 Sep;96(3):396–400. doi: 10.1016/0002-9610(58)90932-2. [DOI] [PubMed] [Google Scholar]
  16. Schweikert H. U. Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital and nongenital skin. Horm Metab Res. 1979 Nov;11(11):635–640. doi: 10.1055/s-0028-1092791. [DOI] [PubMed] [Google Scholar]
  17. Schweikert H. U. Klinik der gestörten Androgenwirkung (Androgenresistenzsyndrome). Klin Padiatr. 1987 Jul-Aug;199(4):245–252. doi: 10.1055/s-2008-1026798. [DOI] [PubMed] [Google Scholar]
  18. Schweikert H. U., Knauf W., Romalo G., Höller W., Bidlingmaier F., Knorr D. Androgen binding in cultured human fibroblasts from patients with idiopathic hypospadias. Horm Metab Res. 1987 Oct;19(10):497–501. doi: 10.1055/s-2007-1011862. [DOI] [PubMed] [Google Scholar]
  19. Schweikert H. U., Milewich L., Wilson J. D. Aromatization of androstenedione by cultured human fibroblasts. J Clin Endocrinol Metab. 1976 Oct;43(4):785–795. doi: 10.1210/jcem-43-4-785. [DOI] [PubMed] [Google Scholar]
  20. Svensson J., Snochowski M. Androgen receptor levels in preputial skin from boys with hypospadias. J Clin Endocrinol Metab. 1979 Sep;49(3):340–345. doi: 10.1210/jcem-49-3-340. [DOI] [PubMed] [Google Scholar]
  21. Walsh P. C., Curry N., Mills R. C., Siiteri P. K. Plasma androgen responce to hCG stimulation in prepubertal boys with hypospadias and cryptorchidism. J Clin Endocrinol Metab. 1976 Jan;42(1):52–59. doi: 10.1210/jcem-42-1-52. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES